Clinical Trial Update: Randomized Trial of ARCON in Larynx Cancer [Phase 3]

View source ↗

Summary

Clinical trial update indicates a Phase 3 randomized trial of ARCON for laryngeal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Cancer

Snippet

Sponsor: Radboud University Medical Center | Conditions: Larynx Carcinoma | Phase 3 | Status: COMPLETED